FATTY LIVER

This study is testing whether erdosteine, a drug already used for other conditions, can safely reduce fat buildup and scarring in the liver of people with nonalcoholic fatty liver disease (NAFLD). About 50 adults with fatty liver will take the drug and be monitored for changes in…

This study tests whether nicotinamide (a form of vitamin B3) can stop or reverse liver scarring in people with fatty liver disease and obesity. Thirty adults with liver fibrosis will take either nicotinamide or a placebo daily for one year. Researchers will measure changes in liv…

This study tests whether time-restricted intermittent fasting can reduce liver fat in non-obese adults (BMI 23-30) with non-alcoholic fatty liver disease (NAFLD). About 25 participants will follow a fasting schedule, and researchers will measure changes in liver fat using advance…

This study tests whether cilostazol, a drug used for blood flow, can reduce fat buildup and scarring risk in the liver. About 50 adults with fatty liver disease will take the drug and be monitored. The goal is to see if it can control the disease and prevent it from getting worse…

This study compares newer CT and ultrasound techniques to standard MRI for finding fat and scarring in the liver. About 45 adults with liver disease will receive a special CT scan, an MRI, and an ultrasound. The goal is to see if these newer methods are as accurate as MRI, which …

This study looks at a blood test called the ELF test to see if it can find early fatty liver disease in people at high risk, such as those with diabetes or heart disease. Researchers will check ELF scores in 300 patients and compare them to other tests like ultrasound or liver bi…

This study follows 1,500 pregnant women and their children for up to 18 years to understand how a mother's health, lifestyle, and environment during pregnancy affect her child's growth and risk for conditions like obesity, diabetes, and fatty liver. Participants are American Indi…